ClinicalTrials.gov
public full text
Public Domain
Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors
RATIONALE: Adenosine triphosphate may decrease weight loss and improve muscle strength in patients with advanced solid tumors. PURPOSE: Phase I trial to study the effectiveness of adenosine triphosphate in controlling loss of weight and loss of muscle mass in patients who have advanced solid tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of JMT203 in Patients With Cancer Cachexia#1378246
- The Survey About Resting Metabolic Rate and Its Related Factors in Terminal Patients#861149
- Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors#1138737
- A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue#1112177
- Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer Treatment#1372007
Record · ID 1487084
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive